Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
618.00
-18.00 (-2.83%)
At close: Jan 30, 2026
Kyung Nam Pharm Market Cap
Kyung Nam Pharm has a market cap or net worth of 53.14 billion as of February 4, 2026. Its market cap has decreased by -19.05% in one year.
Market Cap
53.14B
Enterprise Value
44.44B
Revenue
56.18B
Ranking
n/a
PE Ratio
5.53
Stock Price
618.00
Market Cap Chart
Since March 1, 2002, Kyung Nam Pharm's market cap has increased from 11.99B to 53.14B, an increase of 343.20%. That is a compound annual growth rate of 6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 53.14B | 0.29% |
| Dec 30, 2025 | 52.98B | -15.36% |
| Dec 30, 2024 | 62.60B | 4.56% |
| Dec 28, 2023 | 59.87B | -27.59% |
| Dec 29, 2022 | 82.68B | -6.60% |
| Dec 30, 2021 | 88.52B | -37.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BL Pharmtech | 73.77B |
| Sinil Pharmaceutical | 67.46B |
| Cosmax Nbt | 66.49B |
| Jin Yang Pharmaceutical | 64.55B |
| Korea Arlico Pharm | 62.23B |
| RP Bio | 59.36B |
| Eagle Veterinary Technology Co.,Ltd | 52.59B |
| Korean Drug | 44.36B |